ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

PLSM vs NMTC // OPTIONS IMPLIED MOVE & PUT/CALL SKEW

Pulsenmore Ltd. (NASDAQ) VS. NeuroOne Medical Technologies Corporation (NASDAQ) • 15-METRIC TALLY: PLSM 1 — NMTC 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PLSM VS. NMTC) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC PLSM NMTC SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 56.50% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) — -35.00% — TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin — -46.50% — TIE /operating-margins <GO>
Net Profit Margin — -39.60% — TIE /net-margins <GO>
Revenue Growth (YoY) — 163.50% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality — 5/9 — TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew ACTIVE — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 31.9 40.1 -8.15 NMTC /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $10.5M $8.8M $1.7M PLSM /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR PLSM REV NMTC REV PLSM GROSS % NMTC GROSS % PLSM FCF NMTC FCF
FY 2025 — $9.1M — 56.5% — -$2.9M
FY 2024 — $3.5M — 31.3% — -$11.1M
FY 2023 — $2.0M — — — -$12.9M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PLSM // BETA —
NMTC // BETA —